(Q38509763)

3 September 2017

1 reference

title

Myeloid-derived suppressor cells in immunity and autoimmunity (English)

1 reference

3 September 2017

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26028421%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

author name string

Hui Yang

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26028421%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Yujing Bi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26028421%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Fei Han

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26028421%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Yun Lu

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26028421%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Jian Wang

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26028421%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Zhengguo Zhang

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26028421%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

publication date

31 May 2015

1 reference

Expert Review of Clinical Immunology

3 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26028421%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26028421%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26028421%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

page(s)

911-919

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26028421%20AND%20SRC:MED&resulttype=core&format=json

SIRT1 limits the function and fate of myeloid-derived suppressor cells in tumors by orchestrating HIF-1α-dependent glycolysis

12 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1052794

Regulatory immune cells in transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1052794

Metabolism of L-arginine by myeloid-derived suppressor cells in cancer: mechanisms of T cell suppression and therapeutic perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1052794

Myeloid-derived suppressor cell heterogeneity and subset definition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1052794

The immunosuppressive tumour network: myeloid-derived suppressor cells, regulatory T cells and natural killer T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1052794

Arginase I-producing myeloid-derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1052794

Targeting S1P1 receptor protects against murine immunological hepatic injury through myeloid-derived suppressor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1052794

Distinct signatures of the immune responses in low risk versus high risk neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1052794

Myeloid-derived suppressor cells down-regulate L-selectin expression on CD4+ and CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1052794

IL-6 regulates in vivo dendritic cell differentiation through STAT3 activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1052794

Direct and differential suppression of myeloid-derived suppressor cell subsets by sunitinib is compartmentally constrained

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1052794

Myeloid-specific expression of Api6/AIM/Sp alpha induces systemic inflammation and adenocarcinoma in the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1052794

S100 proteins expressed in phagocytes: a novel group of damage-associated molecular pattern molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1052794

Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1052794

Tumor-mediated inhibition of dendritic cell differentiation is mediated by down regulation of protein kinase C beta II expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1052794

Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1052794

TLR4/MyD88-induced CD11b+Gr-1 int F4/80+ non-migratory myeloid cells suppress Th2 effector function in the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1052794

Effect of tumor-derived cytokines and growth factors on differentiation and immune suppressive features of myeloid cells in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1052794

Overexpression of interleukin-1beta induces gastric inflammation and cancer and mobilizes myeloid-derived suppressor cells in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1052794

C/EBPbeta is required for 'emergency' granulopoiesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1052794

Tumor-induced tolerance and immune suppression depend on the C/EBPbeta transcription factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1052794

Effect of NKG2D ligand expression on host immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1052794

Contributions of the host microenvironment to cancer-induced bone disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1052794

Getting to the site of inflammation: the leukocyte adhesion cascade updated

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1052794

Coordinated regulation of myeloid cells by tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1052794

Antigen-presenting dendritic cells provide the reducing extracellular microenvironment required for T lymphocyte activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1052794

Myeloid-derived suppressor cells inhibit T-cell activation by depleting cystine and cysteine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1052794

Bone marrow myeloid-derived suppressor cells (MDSCs) inhibit graft-versus-host disease (GVHD) via an arginase-1-dependent mechanism that is up-regulated by interleukin-13

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1052794

L-arginine metabolism in myeloid cells controls T-lymphocyte functions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1052794

Regulation of T cell receptor CD3zeta chain expression by L-arginine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1052794

Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1052794

Tumor cells convert immature myeloid dendritic cells into TGF-beta-secreting cells inducing CD4+CD25+ regulatory T cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1052794

Myeloid-derived suppressor cells promote cross-tolerance in B-cell lymphoma by expanding regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1052794

Immune stimulatory receptor CD40 is required for T-cell suppression and T regulatory cell activation mediated by myeloid-derived suppressor cells in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1052794

Targeting natural killer cells and natural killer T cells in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1052794

Transforming growth factor-beta production and myeloid cells are an effector mechanism through which CD1d-restricted T cells block cytotoxic T lymphocyte-mediated tumor immunosurveillance: abrogation prevents tumor recurrence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1052794

Arginase, prostaglandins, and myeloid-derived suppressor cells in renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1052794

Activated NKT cells and NK cells render T cells resistant to myeloid-derived suppressor cells and result in an effective adoptive cellular therapy against breast cancer in the FVBN202 transgenic mouse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1052794

Invariant NKT cells reduce the immunosuppressive activity of influenza A virus-induced myeloid-derived suppressor cells in mice and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1052794

CCR2+Ly-6Chi monocytes are crucial for the effector phase of autoimmunity in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1052794

Circulating Ly-6C+ myeloid precursors migrate to the CNS and play a pathogenic role during autoimmune demyelinating disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1052794

Innate immune CD11b+Gr-1+ cells, suppressor cells, affect the immune response during Theiler's virus-induced demyelinating disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1052794

Adjuvant immunotherapy is dependent on inducible nitric oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1052794

Direct activation of innate and antigen-presenting functions of microglia following infection with Theiler's virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1052794

Hepatic acute-phase proteins control innate immune responses during infection by promoting myeloid-derived suppressor cell function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1052794

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1052794

Type 1 T helper cells induce the accumulation of myeloid-derived suppressor cells in the inflamed Tgfb1 knockout mouse liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1052794

Gr-1+CD115+ Immature Myeloid Suppressor Cells Mediate the Development of Tumor-Induced T Regulatory Cells and T-Cell Anergy in Tumor-Bearing Host

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1052794

Regulation of triggering receptor expressed on myeloid cells 1 expression on mouse inflammatory monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1052794

10.1586/1744666X.2015.1052794

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26028421%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

1 reference